A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma

Trial Profile

A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2015

At a glance

  • Drugs PG 2 (Primary)
  • Indications Fatigue
  • Focus Therapeutic Use
  • Sponsors PhytoHealth
  • Most Recent Events

    • 03 Nov 2015 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
    • 29 Apr 2015 New trial record
    • 27 Apr 2015 Planned End Date changed from 1 Oct 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top